Bilcare’s subsidiary Bilcare Technologies is reportedly planning to raise around Rs 200-300 crore through offloading 26% stake to a strategic or financial partner. In this regard, the company has mandated financial service provider Tata Capital to look for a partner. The company will use the raised fund for its future growth and market its various products across the globe. The company invested around $100 million in the core technology over the past 5 years.
Bilcare Technologies has developed non-clonable identity or nCID chips for anti-counterfeiting and tracking products ranging from pharmaceuticals to liquor. Bilcare is engaged in manufacturing pharmaceutical packaging. It has an experience of working with 500 pharma manufacturing companies worldwide.
